Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
230 | 3784 | 31.5 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1442 | 7319 | MYASTHENIA GRAVIS//AGRIN//ACETYLCHOLINE RECEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MYASTHENIA GRAVIS | Author keyword | 1068 | 56% | 35% | 1315 |
2 | THYMECTOMY | Author keyword | 144 | 47% | 6% | 224 |
3 | EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS | Author keyword | 72 | 66% | 2% | 67 |
4 | SERONEGATIVE MYASTHENIA GRAVIS | Author keyword | 56 | 89% | 1% | 25 |
5 | JUVENILE MYASTHENIA GRAVIS | Author keyword | 48 | 100% | 0% | 17 |
6 | SINGLE FIBER ELECTROMYOGRAPHY | Author keyword | 44 | 54% | 2% | 57 |
7 | MYASTHENIC CRISIS | Author keyword | 42 | 71% | 1% | 34 |
8 | ACETYLCHOLINE RECEPTOR ANTIBODY | Author keyword | 40 | 66% | 1% | 37 |
9 | MAIN IMMUNOGENIC REGION | Author keyword | 38 | 93% | 0% | 14 |
10 | OCULAR MYASTHENIA GRAVIS | Author keyword | 35 | 76% | 1% | 25 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAXIMAL THYMECTOMY | 179 | 95% | 2% | 59 |
2 | ACETYLCHOLINE RECEPTOR ANTIBODIES | 172 | 77% | 3% | 117 |
3 | TRANS CERVICAL THYMECTOMY | 130 | 97% | 1% | 36 |
4 | ACETYLCHOLINE RECEPTOR ANTIBODY | 127 | 75% | 2% | 92 |
5 | MAIN IMMUNOGENIC REGION | 121 | 62% | 3% | 125 |
6 | EXTENDED THYMECTOMY | 119 | 79% | 2% | 76 |
7 | SERONEGATIVE MG | 107 | 97% | 1% | 31 |
8 | THYMECTOMY | 102 | 41% | 5% | 196 |
9 | TRANSCERVICAL THYMECTOMY | 90 | 88% | 1% | 43 |
10 | GRAVIS | 84 | 37% | 5% | 181 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity | 2009 | 186 | 140 | 88% |
MEDICAL PROGRESS - MYASTHENIA-GRAVIS | 1994 | 800 | 101 | 65% |
Myasthenia gravis - Recommendations for clinical research standards | 2000 | 408 | 38 | 68% |
Lifetime course of myasthenia gravis | 2008 | 92 | 16 | 100% |
Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology | 2000 | 200 | 17 | 100% |
Myasthenia gravis: past, present, and future | 2006 | 192 | 109 | 71% |
An update on laboratory diagnosis in myasthenia gravis | 2015 | 2 | 26 | 81% |
Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4 | 2013 | 28 | 101 | 78% |
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes | 2013 | 31 | 125 | 65% |
A systematic review of population based epidemiological studies in Myasthenia Gravis | 2010 | 60 | 38 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROL MED SERV | 9 | 83% | 0.1% | 5 |
2 | NEUROIMMUNOL DMSC | 8 | 100% | 0.1% | 5 |
3 | UNIT MYASTHENIA GRAVIS | 8 | 100% | 0.1% | 5 |
4 | MYASTHENIA GRAVIS UNIT | 6 | 80% | 0.1% | 4 |
5 | NEUROIMMUNOL NEUROMUSCULAR DIS | 6 | 71% | 0.1% | 5 |
6 | NEUROMUSCULAR INVEST | 6 | 71% | 0.1% | 5 |
7 | MULTIDISCIPLINARY MYASTHENIA GRAVIS UNIT | 6 | 100% | 0.1% | 4 |
8 | MCB NEUROPHYSIOL | 4 | 67% | 0.1% | 4 |
9 | CLIN NEUROLNEUROSCI GRP | 4 | 75% | 0.1% | 3 |
10 | CNRS URA 1159 | 4 | 50% | 0.2% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000206989 | DS DNA ANTIBODIES//INTERNAL AUTOIMMUNE METAB DIS//CHU PITIE SALPETRIERE HP |
2 | 0.0000178379 | CONGENITAL MYASTHENIC SYNDROME//CONGENITAL MYASTHENIC SYNDROMES//TUBULAR AGGREGATES |
3 | 0.0000142076 | CONTACT PHOTOLITHOGRAPHY//GEN HOSP G P ANICOLAOU//MEDICAL OUTCOMES STUDY 36 ITEM SHORT FORM HEALTH SURVEY SF 36 |
4 | 0.0000072471 | THYMOMA//THYMIC CARCINOMA//THYMOLIPOMA |
5 | 0.0000065981 | AMBENONIUM//NEOSTIGMINE BROMIDE//CENTRAL CONTROL OF CARDIAC FREQUENCY |
6 | 0.0000061159 | D PENICILLAMINE//MESANGIAL GLOMERULOPATHY//ANTIACETYLCHOLINE RECEPTOR ANTIBODIES |
7 | 0.0000045521 | CHAIR BIOPHYS MOL NEUROBIOL//NICOTINIC ACETYLCHOLINE RECEPTOR//CYS LOOP RECEPTORS |
8 | 0.0000043740 | PARANEOPLASTIC CEREBELLAR DEGENERATION//LAMBERT EATON MYASTHENIC SYNDROME//ANTI HU ANTIBODIES |
9 | 0.0000039001 | AGRIN//NEUROMUSCULAR JUNCTION//ACETYLCHOLINE RECEPTORS |
10 | 0.0000036209 | THERAPEUTIC APHERESIS//THERAPEUTIC PLASMA EXCHANGE//PLASMA EXCHANGE |